You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

The Silent Thief: Diagnosis and Management of Osteoporosis

Kamienski, Mary; Tate, Denise; Vega, CPT Marielos

Orthopaedic Nursing:
doi: 10.1097/NOR.0b013e318219ab9d
Original Articles
Abstract

Osteoporosis causes approximately 1.5 million fractures every year in the United States. Not only can these fractures be painful and disfiguring but they may reduce a person's ability to lead an active life as well. Osteoporosis affects every bone in the body, but the most common places where fractures occur are the back, hips, and wrists. Because osteoporosis thins bones, weakening them and making them more susceptible to fractures, practitioners must understand the risk factors and the diagnosis and management of this very common problem. This article, geared toward advanced practice nurses, presents a summary of the latest diagnostic tests and medication treatments available and approved by the Food and Drug Administration for the management of osteoporosis.

Author Information

Mary Kamienski, PhD, APRN FAEN, Assistant Dean, Graduate Program, UMDNJ School of Nursing, and Associate Professor, University of Medicine and Dentistry of New Jersey, Newark.

Denise Tate, EdD, APRN, Assistant Dean, Pre-Licensure Program Newark Campus, UMDNJ School of Nursing, Newark.

Marielos Vega, MSN, US Army Nursing Corp, Brooke Army Medical Center, San Antonio, TX.

The authors have disclosed that they have no financial interests to any commercial company related to this educational activity.

© 2011 National Association of Orthopaedic Nurses